Randomized Trial of Plasma ctDNA Methylation-Guided Adjuvant Therapy in T4N0 and Low-Risk Stage III Colorectal Cancer

NCT07562503 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

340

Enrollment

OTHER

Sponsor class

Conditions

ctDNA
Colorectal Cancer
Chemotherapy

Interventions

DRUG: CAPEOX regimen
DRUG: CAPEOX regimen

Sponsor

Fudan University